The impact of workload changes and staff availability on IV chemotherapy services.
- Published in:
- Journal of Oncology Pharmacy Practice, 2003, v. 9, n. 4, p. 123, doi. 10.1191/1078155203jp112oa
- By:
- Publication type:
- Article
Works matching IS 10781552 AND DT 2003 AND VI 9 AND IP 4
Results: 5
1
2
Clinical pharmacokineticsand metabolism of paclitaxel after a three-hour infusion: comparison of two preparations.
- Published in:
- Journal of Oncology Pharmacy Practice, 2003, v. 9, n. 4, p. 129, doi. 10.1191/1078155203jp113oa
- By:
- Publication type:
- Article
3
Palmar-plantar erythrodysesthesia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2003, v. 9, n. 4, p. 137, doi. 10.1191/1078155203jp114oa
- By:
- Publication type:
- Article
4
Gefitinib (ZD1839, Iressa[sup ®]): a selective epidermal growth factor receptor-tyrosine kinase inhibitor.
- Published in:
- Journal of Oncology Pharmacy Practice, 2003, v. 9, n. 4, p. 151, doi. 10.1191/1078155203jp115oa
- By:
- Publication type:
- Article
5
Pyridoxine treatment and prevention of hand-and-foot syndrome in patients receiving capecitabine.
- Published in:
- Journal of Oncology Pharmacy Practice, 2003, v. 9, n. 4, p. 161, doi. 10.1191/1078155203jp116oa
- By:
- Publication type:
- Article